A Case of Kawasaki Disease Shock Syndrome with Concomitant Pantoea spp Sepsis

Angelina Grace   C. Robles,

A Case of Kawasaki Disease Shock Syndrome with Concomitant Pantoea spp Sepsis

Abstract:

Inflammatory bowel disease is a chronic disorder of the gastrointestinal tract that usually affects adolescents and young adults. It is rare among infants making up only less than 1% of pediatric cases. This is a case of infantile inflammatory bowel disease who presented with early onset hematochezia, with colonoscopy and histopathologic findings consistent with ulcerative colitis. He was managed with mesalazine, a 5-ASA derivative, the mainstay of treatment.

References:

Yim, D., et al. Coronary Artery Dilatation in Toxic Shock-Like Syndrome: The Kawasaki Disease Shock Syndrome. Pediatr Cardiol. 2010; 31(8): 1232. 2010 Aug 13.
Kanegaye JY, Wilder MS, Mokara D., et al. Recognition of Kawasaki Disease Shock Syndrome. Pediatrics. 2009; 123 e783-e789.
Gatterre P, Oulha M, et al. Kawasaki Disease: An Unexpected Etiology of Shock and Multiple Organ Dysfunction Syndrome. Intensive Care Med. 2012; 38: 872-878.
Zhang, M., et al. Clinical Analysis of Kawasaki Disease Shock Syndrome. Chinese Medical Journal. 2017; 130(23).
Kliegman R, Bonita S, et al. Nelson Textbook of Pediatrics. 21st Edition.
Dominguez, SR, Friedman K, Seewald R, et al. Kawasaki Disease in a Pediatric Intensive Care Unit: A Case Control Study. Pediatrics. 2008; 122: e786-e790.
Siwakoti, S., et al. Pantoea Agglomerans Infections in Children: Report of Two Cases. Hindawi Case Reports in Pediatrics. 2018.
Hussein, A., Al-Kadmy, I., et al. Distribution of Pantoea Agglomerans Isolates and Molecular Detection of blaPER-1 ESBL Gene: A Statistical Study. Elsevier Ltd. 2020; Volume 147, October 2020, 104374.
Cruz, AT., et al. Pantoea Agglomerans, a Plant Pathogen Causing Human Disease. Journal of Clinical Microbiology. 2007; 61(3): 1989-1992.
Kaur, IP., et al. Pantoea Agglomerans Bacteremia: Is It Dangerous? Hindawi Case Reports in Infectious Diseases. 2020.
Cohen Tervaert JW, et al. The Role of Superantigens in Vasculitis. Curr Opin Rheumatol. 1999; 11: 24-33.
Alhammadi, A. and Hendaus, M. Comorbidity of Kawasaki Disease and Group A Streptococcal Pleural Effusion in a Healthy Child: A Case Report. International Journal of General Medicine. 2013; 6: 613–616.
Insights Imaging. 2010 Sep; 1(4): 223-231. Published online 2010 Jul 30.
Lin MT, Fu CM, et al. Population-Based Study of Kawasaki Disease Shock Syndrome in Taiwan. Pediatric Infectious Disease Journal. 2013; 32(12): 1384-1386.
Cakan, M., Gemici, H., et al. Kawasaki Disease Shock Syndrome: A Rare and Severe Complication of Kawasaki Disease. The Turkish Journal of Pediatrics. 2016; 58: 415-418.
McCrindle, B.W., Cifra, B. The Role of Echocardiography in Kawasaki Disease. International Journal of Rheumatic Disease. 2018; 21(1): 50-55.
Nakamura Y., et al. Mortality Among Patients with a History of Kawasaki Disease: The Third Look. The Kawasaki Disease Follow-up Group. Acta Pediatric Jpn. 1998; 40(5): 419.
Gonzalez, L., Moribe-Quintero, I., et al. Kawasaki Disease Shock Syndrome: Unique and Severe Subtype of Kawasaki Disease. Pediatrics International. 2018; 60(9).
Hirata S., et al. Incidence Rate of Recurrent Kawasaki Disease and Related Risk Factors: From the Results of Nationwide Surveys of Kawasaki Disease in Japan. Acta Pediatric. 2001; 90(1): 40.
Stockheim, J., et al. Kawasaki Disease in Older Children and Adolescents. The Journal of Pediatrics.
Lin, YF, et al. Early Differentiation of Kawasaki Disease Shock Syndrome and Toxic Shock Syndrome in a Pediatric Intensive Care Unit. Pediatric Infect Dis J. 2015; 34: 1163-1167.